KTRA insider transaction filings
Kintara Therapeutics, Inc. — 6 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-10-22. Screen KTRA transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for KTRA between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.
Recent Form 4 filings — Kintara Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-10-22 | 4 | Yamashita Dennis — Chief Scientific Officer | Grant/award (A): 196,790 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | Ng George K — Director | Grant/award (A): 35,780 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | List Alan — Director | Grant/award (A): 13,553 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | Dearborn Dan — Chief Financial Officer | Grant/award (A): 33,991 (derivative) @ $0 · Grant/award (A): 68,438 (derivative) @ $0 · Grant/award (A): 232,570 (derivative) @ $0 · Grant/award (A): 15,744 (derivative) @ $0 · Grant/award (A): 66,658 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 13,553 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | Bianco James A. — Chief Executive Officer, Director | Grant/award (A): 2,323,307 @ $0 · Grant/award (A): 357,800 (derivative) @ $0 · Grant/award (A): 71,560 (derivative) @ $0 · Grant/award (A): 191,280 (derivative) @ $0 | EDGAR |
Recent 8-K events — Kintara Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-04 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-21 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-19 | 8-K | 3.02 — Unregistered Sales of Equity Securities 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | ? | EDGAR |
| 2026-05-29 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KTRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →